• Seeking Alpha

MannKind to Highlight Data from Recent Pediatric and Adult Studies of Inhaled Insulin (Afrezza®) at American Diabetes Association’s 85th Scientific Sessions in Chicago, June 20-23

Seeking Alpha / 46 minutes ago 1 Views

MannKind to Highlight Data from Recent Pediatric and Adult Studies of Inhaled Insulin (Afrezza®) at American Diabetes Association’s 85th Scientific Session
Read more
  • Source:
  • GlobeNewswire - News about Public Companies
Previous post
Lulus Announces Approval of Equity Listing Transfer to Nasdaq Capital Market
Next post
Registration Is Now Open For Tribe Public’s CEO Presentation and Q&A Webinar Event "Is the Beaten Down Biotech Sector the Smartest Bet in Today's Volatile Market?"

Comments

Just Posted

  • Cibus, Inc. Announces Closing of $27.5 Million Public Offering

    3 hours from now

  • Itron Launches Cyble 5 Module in APAC Region to Transform Water Utility Operations

    3 hours from now

  • MediPharm Labs’ Founder-CEO Pat McCutcheon Throws his Support behind Apollo Capital as Dissident

    2 hours from now

  • Thirteen Studies of Ascentage Pharma’s Assets Including Olverembatinib and Lisaftoclax Selected for Presentations at 2025 European Hematology Association Annual Congress

    2 hours from now

  • Avista reaches all-party, all issues settlement in Idaho general rate cases

    2 hours from now

Tags

  • SA Transcripts
  • TOU:CA
  • Gold Mining Bull
  • TPZ
  • NG1:COM
  • CHK
  • TRMLF
  • fivn
  • CGIFF
  • CHE.UN:CA

Reviews

Categories

  • Seeking Alpha 949

Categories

  • Seeking Alpha 949

Pages

Tags

  • SA Transcripts
  • TOU:CA
  • Gold Mining Bull
  • TPZ
  • NG1:COM
  • CHK
  • TRMLF
  • fivn
  • CGIFF
  • CHE.UN:CA

Copyright News That Move � 2018. All Rights Reserved

  • Seeking Alpha
  • Trade Halts